Showing results (81-90 of 149) with videos related to
Sort By:
Pageof 15
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 19, 2015
Durable brain response with pulse-dose crizotinib and ceritinib in ALK-positive non-small cell lung cancer compared with brain radiotherapyElizabeth Dudnik, Tali Siegal, Leor Zach, et al.Journal of Neuro-Oncology|September 23, 2015
MicroRNA as potential biomarkers in GlioblastomaZammam Areeb, Stanley S Stylli, Rachel Koldej, et al.American Journal of Hematology|November 3, 2016
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapyAdir Shaulov, Chezi Ganzel, Noam Benyamini, et al.European Journal of Haematology|October 5, 2012
Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study GroupOsnat Bairey, Neta Goldschmidt, Rosa Ruchlemer, et al.International Journal of Clinical and Experimental Medicine|May 9, 2012
Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promotersDoron Amit, Imad J Matouk, Iris Lavon, et al.Journal of Neuro-Oncology|August 31, 2016
Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patientsTal Shahar, Avital Granit, Daniel Zrihan, et al.Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|November 3, 2023
Significant Systemic Insulin Resistance is Associated With Unique Glioblastoma Multiforme PhenotypeYosef Laviv, Eilat Sapirstein, Andrew A Kanner, et al.European Journal of Haematology|February 18, 2018
Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosisMarjorie Pick, Vladimir Vainstein, Neta Goldschmidt, et al.Journal of Neurosurgery|January 23, 2016
Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumabTali Siegal, Hanna Charbit, Iddo Paldor, et al.Endocrine-Related Cancer|May 27, 2006
The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-RDavid J Gross, Gabriel Munter, Menachem Bitan, et al.Pageof 15